阻断链转移的抑制剂,可以防止细胞的融合,并抑制HIV-1在细胞中的复制
D J Hazuda1, P Felock, M Witmer
1Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA. daria-hazuda@merck.com
概括
新的二基酸抑制剂向人体免疫缺陷病毒1型 (HIV-1) 整合酶,特别是阻断链转移功能. 这种机制有效地抑制病毒复制,提供了一个有希望的抗病毒策略.
科学领域:
- 病毒学 病毒学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 人类免疫缺陷病毒1型 (HIV-1) 整合酶是病毒复制的关键酶.
- 以前针对孤立的HIV-1整合酶的抑制剂显示出有限的抗病毒疗效.
- 整合酶抑制的精确机制及其转化为抗病毒活性需要进一步阐明.
研究的目的:
- 为了识别和描述HIV-1整合酶的新型抑制剂.
- 调查这些抑制剂发挥抗病毒活性的机制.
- 确定抗病毒疗效与抑制特定整合酶功能的相关性.
主要方法:
- 对二基酸化合物的合成和生物化学评估.
- 测试用于测量HIV-1整合酶酶活性的抑制.
- 基于细胞的测试以评估抗病毒活性对抗HIV-1复制.
主要成果:
- 迪克托酸化合物被确定为HIV-1整合酶的强有力的抑制剂.
- 这些抑制剂在细胞培养中表现出显著的抗病毒活性.
- 抗病毒活性仅归因于抑制整合酶的链转移功能.
结论:
- 狄基托酸抑制剂代表了一类新的抗HIV-1药物.
- 针对HIV-1整合酶的链转移活性是抗病毒治疗的可行策略.
- 这些发现为开发抗HIV-1新药提供了基础.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


